Protocol for a Prospective, Observational Cost-effectiveness Analysis of Returning Secondary Findings of Genome Sequencing for Unexplained Suspected Genetic Conditions.
Ungar WJ, Hayeems RZ, Marshall CR, Gillespie MK, Szuto A, Chisholm C, James Stavropoulos D, Huang L, Jarinova O, Wu V, Tsiplova K, Lau L, Lee W, Venkataramanan V, Sawyer S, Mendoza-Londono R, Somerville MJ, Boycott KM; Genome Sequencing Ontario Secondary Findings Study Team.
Ungar WJ, et al. Among authors: venkataramanan v.
Clin Ther. 2023 Aug;45(8):702-709. doi: 10.1016/j.clinthera.2023.06.004. Epub 2023 Jul 14.
Clin Ther. 2023.
PMID: 37453830